Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
cancer
3
×
life sciences
national blog main
avapritinib
biotech
blueprint medicines
boston
boston top stories
clinical trials
eli lilly
indiana blog main
indiana top stories
national top stories
novartis
san francisco blog main
san francisco top stories
abbvie
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
alzheimer's disease
andrew berens
antibiotics
axial spondyloarthritis
bausch health
biogen
boston university
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer drugs
cancer immunotherapy
capmatinib
car-t immunotherapy
cell therapy
cluster headache
crispr
What
approval
3
×
drug
blueprint
cancer
fda
address
announced
approves
bio
biogen’s
biopharmaceutical
carries
certain
chasing
companies
convo
deadly
deciphera
designed
earlier
failures
filing
forms
genetic
gi
latest
littered
medicine
medicines
morning
nash
new
news
pass
pharamceuticals
plans
price
remains
ret
road
Language
unset
Current search:
approval
×
cancer
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More